Andhra Paper Limited Overview
Andhra Paper Limited is a mid-sized, fully integrated wood-based pulp and paper manufacturer anchored in the Godavari delta of Andhra Pradesh, operating two mills at Rajahmundry and Kadiyam with approximately 2,59,400 TPA of paper and 2,20,500 TPA of virgin pulp capacity. It is the only paper mill in Andhra Pradesh producing from virgin pulp, a structural cost and quality advantage over recycled-fibre and market-pulp-dependent peers. Its portfolio is concentrated in uncoated writing & printing (W&P) paper — maplitho, offset and copier grades — with a smaller paperboard presence and a 35,000 TPA tissue line under construction at Kadiyam. Since October 2019 it has been a 72%-owned subsidiary of West Coast Paper Mills, giving the Bangur group roughly 5.8 lakh TPA of combined paper capacity. The company carries a net-cash balance sheet and AA-category credit rating, but its earnings are highly cyclical, import-sensitive and, in 2025–26, repeatedly disrupted by labour unrest.
What the company does
Andhra Paper converts plantation and farm-forestry hardwood (principally eucalyptus, subabul and casuarina sourced from Andhra Pradesh and neighbouring states) into bleached chemical pulp in its own fibre lines, then converts that pulp into finished paper and paperboard on multiple paper machines. Its filings define a single reportable segment: "manufacture and sale of pulp, paper and paperboard" (Integrated Filing, Q4 FY2026, NSE, 14 May 2026). The company describes itself in its Annual Report 2024-25 as one of India's leading integrated paper and pulp manufacturers, present across writing, printing, industrial and copier paper, and as the only paper mill in Andhra Pradesh using virgin pulp.
Business and revenue model
Product revenue model (≈100%): Revenue is generated almost entirely from the sale of manufactured paper (and limited paperboard and saleable pulp). There is no subscription, licensing or service revenue. Other income (treasury income on a sizeable investment book) is material to profit but sits below revenue.
Volume × realisation economics: FY2026 sales were a record 2,60,438 MT on turnover of ₹1,692.98 cr, implying an average realisation of roughly ₹65,000/MT (derived), down from ~₹83,200/MT at the FY2023 cycle peak (derived from the Annual Report 2024-25 six-year highlights).
Channel: Sales flow predominantly through a dealer/distributor network to printers, publishers, stationery and notebook converters, and to institutional buyers including government textbook and examination printing programmes. Copier paper reaches corporate and retail channels through distributors. The precise channel mix is not publicly disclosed.
Backward integration: Captive pulping (hardwood kraft with ECF bleaching at Rajahmundry), chemical recovery (recovery boilers, lime kiln) and captive power reduce exposure to imported market pulp — a key differentiator versus non-integrated mills.
Value-chain position
Andhra Paper sits in the upstream-to-midstream portion of the paper value chain: wood procurement → pulping → papermaking → sheeting/reeling. It does not, at present, participate meaningfully in downstream converting (notebooks, packaging) or in distribution, both of which are handled by third parties. The tissue project will extend it into a consumer-adjacent category (parent reels for bath, towel, facial and napkin converters).
Customer types and end-markets
| Customer type | End-market | Products |
|---|---|---|
| Commercial and book printers | Publishing, textbooks, commercial print | Maplitho, offset, cream wove |
| Notebook and stationery converters | Education and stationery | Maplitho, cream wove, ruled-paper parent reels |
| Corporates and offices (via distributors) | Office documentation | Copier / multipurpose paper |
| Government and institutional printers | Textbooks, examinations, forms | W&P grades |
| Packaging converters | FMCG/pharma secondary packaging | Paperboard (Kadiyam) |
| Tissue converters (future) | Hygiene / HoReCa | Tissue parent reels (planned 35,000 TPA) |
Independent characterisation
Andhra Paper is best understood as a cost-competitive, single-product-family commodity producer whose earnings are dictated by the domestic W&P price cycle, wood costs and import parity (ASEAN and Chinese supply). FY2023's record profit (₹522 cr PAT) was a cycle-peak anomaly; FY2025–FY2026 show the downside, with net margins compressing to ~1%. Management is responding by (a) debottlenecking and modernising Rajahmundry (PM-3 rebuild, fibreline rebuild), (b) diversifying into tissue, and (c) holding a larger greenfield paperboard project in reserve. The strategic overlay is its parent: WCPM controls the board, appoints the managing director (Saurabh Bangur) and shares the group's import-protection advocacy through the Indian Paper Manufacturers Association (IPMA).
Strategy
Stated strategy themes (Annual Report 2024-25, "Committed to a Greener Future / Sustainable Thinking")
The annual report frames strategy around four themes (paraphrased): (1) superior paper quality and expanded capacity through machine upgrades (e.g., PM-5 film-press size press); (2) sustainability, positioning paper as a renewable alternative to plastic and emphasising responsibly sourced fibre, water and energy efficiency; (3) portfolio diversification into tissue and potentially paperboard; and (4) operational resilience in the face of import competition and cost pressure.
Strategic initiatives — last 24 months
| Initiative | Announced | Investment | Status (Oct 2026) | Strategic intent |
|---|---|---|---|---|
| Tissue machine, Kadiyam (35,000 TPA) | Feb 2024 (approval); May–Jun 2024 (Valmet contract) | ₹270 cr | Under installation; CWIP ₹279 cr at Mar 2026; start-up slipped beyond end-2025 target | Enter a structurally growing, less import-exposed category; diversify away from W&P |
| PM-3 rebuild, Rajahmundry (+60 TPD) | 5 Aug 2025 | ₹178 cr | In execution; 13-month schedule (≈ Q3 FY2027) | Add ~20,000 TPA (derived) of core W&P capacity at a mill running at full utilisation; funded by internal accruals/bank debt |
| Valmet cooking, fibreline & evaporation rebuild | Jan 2023 | — | Executed (scheduled Dec 2023) | Pulp yield, chemical and energy efficiency |
| ANDRITZ recovery-boiler upgrade and sustainable technologies | Date not confirmed | — | Not confirmed | Chemical recovery, steam/power efficiency, emissions |
| Additional pulp capacity | Consent to operate Jun 2024 | — | Operational consent obtained | Pulp self-sufficiency to support more paper |
| Greenfield integrated paperboard project (KA#4) | In-principle Jan 2023 | ~₹2,000 cr | Awaiting final board approval subject to MoEFCC environmental clearance; no further progress disclosed | Large-scale entry into virgin paperboard (+2,21,000 TPA pulp, +1,56,000 TPA board) |
| Domestic maplitho volume push | FY2026 | — | Delivered: maplitho +63% | Fill capacity, defend domestic share against imports |
| Trade-remedy advocacy (via IPMA/parent) | 2025–2026 | — | DGTR initiated countervailing-duty probe on Indonesian uncoated W&P paper (30 Sep 2026) | Restore domestic pricing power |
Management targets and guidance
Andhra Paper does not publish formal medium-term financial targets (revenue, margin or ROCE goals) or quarterly guidance. The only forward-looking operational statement in the latest filing is that Kadiyam had resumed at ~93% of normal capacity after the July 2026 restart and that management is working to restore full operations (Q1 FY2027 results, 4 Aug 2026). Analyst consensus targets are not available.
Products & Services
All products sit within the single pulp-paper-paperboard segment. Brand names used by the company in trade channels are not disclosed in the filings reviewed and are therefore not listed (to avoid unverifiable attribution). Pricing is market-determined (spot/dealer price lists) and not publicly disclosed.
Writing & printing papers (core; >75% of group revenue is W&P per ICRA's group view)
| Product | Description / key specifications | Target customer | Status / notes |
|---|---|---|---|
| Maplitho paper | Uncoated woodfree paper for printing and notebooks, typically 54–90 gsm | Notebook converters, textbook and commercial printers | Volume leader in FY2026: 1,47,043 MT sold (+63% YoY) |
| Offset printing paper | Uncoated woodfree with surface sizing suited to offset presses (PM-5 size-press upgrade improves surface strength) | Commercial printers, publishers | Ongoing |
| Cream wove | Shade-tinted uncoated paper | Notebook, register and stationery makers | Ongoing |
| Copier / multipurpose paper | Cut-size A4/FS reams, ~70–80 gsm; PM-6 (Voith) was built for UFS and copier grades | Offices, retail, institutions | Ongoing; India maintains anti-dumping duty on uncoated copier paper from Indonesia/Singapore (imposed 2018, sunset-reviewed) |
| Office documentation papers | Multipurpose papers for home and commercial use | Corporate/retail | Ongoing (described by Simply Wall St company profile) |
| Industrial / specialty papers | Industrial-grade and specialty uncoated papers | Industrial converters | Mentioned in Directors' Report FY2025; volumes not disclosed |
Paperboard
| Product | Description | Target customer | Status |
|---|---|---|---|
| Paperboard (Kadiyam) | Board grades from existing Kadiyam capacity (~87,000 TPA existing production capacity referenced in Jan 2023 filing) | Packaging converters | Ongoing; greenfield expansion (KA#4) held at in-principle stage |
Pulp
| Product | Description | Status |
|---|---|---|
| Bleached hardwood kraft pulp (ECF) | Captive virgin pulp, ~2,20,500 TPA capacity; Valmet cooking/fibreline/evaporation rebuild | Primarily captive; consent to operate for additional pulp capacity received Jun 2024 |
| Wet-lap pulp | Historic Wet Lap Machine No. 3 (100 BDTPD) | Legacy; current saleable volume not disclosed |
Tissue (under development)
| Attribute | Detail |
|---|---|
| Machine | Valmet Advantage DCT100HS crescent-former tissue machine with OptiFlo TIS II headbox, Advantage Steel Yankee, ViscoNip press, ReDry, gas-heated AirCap hood, rewinders; Valmet DNA DCS and Valmet IQ QCS |
| Width / speed | 2,850 mm on reel; up to 2,000 m/min |
| Capacity | 35,000 TPA (~100–129 TPD) |
| Grades | Bath, towel, facial and napkin tissue |
| Capex | ₹270 cr approved (Feb 2024); Valmet contract ~₹125 cr |
| Timeline | Start-up originally scheduled end-2025 (Valmet, Jun 2024); capital work-in-progress rose from ₹29.8 cr (Mar 2025) to ₹279.0 cr (Mar 2026), consistent with installation in progress. Commercial start-up had not been confirmed in filings reviewed as of 19 Oct 2026. |
Financial Narrative
Basis: Standalone, Ind AS, INR crore unless stated. FY2022–FY2025 income-statement lines from TipRanks/S&P data cross-checked with Annual Report 2024-25 (six-year highlights) and Directors' Report FY2025; FY2026 from NSE results filing (14 May 2026) and company release. EBITDA from Annual Report 2024-25 six-year highlights (company definition, includes other income) and FY2026 results release.
Income statement
Notes: FY2026 EPS derived (₹18.62 cr ÷ 19.886 cr shares). FY2022 and FY2023 dividends were ₹7.50 and ₹12.50 per ₹10 share respectively (BSE filing May 2022; Equitymaster), restated ÷5 for the 2024 sub-division. FY2024 dividend not confirmed in sources reviewed. FY2021 (pre-window) revenue was ₹886.7 cr with a small net loss of ~₹0.46 cr (TipRanks).
Margins and growth
Revenue CAGR FY2022–FY2026 (derived): ~5.6% p.a. (₹1,366.9 cr → ₹1,701.2 cr). Measured from the FY2023 peak, revenue has contracted at ~6.7% p.a.
Operating volumes and unit economics
Source: Annual Report 2024-25 six-year highlights (FY2022–FY2025); FY2026 results release. Per-tonne figures derived.
Commentary — income statement. The five-year arc is a full commodity cycle. FY2022–FY2023 benefited from post-COVID restocking, a global pulp/paper price spike and constrained imports; realisation per tonne rose ~46% and EBITDA per tonne nearly tripled to ~₹31,400, producing a 37% EBITDA margin and record ₹522 cr PAT. From FY2024, realisations retreated as ASEAN and Chinese imports surged (industry data cite a 34% rise in imports in FY2024), while hardwood costs rose. FY2025 was further hit by a 28-day workmen strike, a 22-day planned maintenance shutdown, a 5% rise in total expenses and higher finance costs tied to tissue-project capex (Directors' Report FY2025). FY2026 delivered record volumes but EBITDA per tonne fell to ~₹5,800 — roughly one-fifth of the peak — because of elevated wood costs, fixed charges, the Q2 strike/shutdown and the mix shift to maplitho. Note also that FY2025 PAT was supported by ~₹37 cr of non-operating gains (Simply Wall St), and in Q1 FY2027 other income was ~53% of PBT (MarketsMojo), underlining the importance of treasury income to reported profit.
Quarterly trajectory (most recent six quarters)
Sources: Arihant/CMOTS quarterly data (Q1–Q2 FY2026); Arthneeti (sales and expenses Q3–Q4); Business Standard/Capital Market (Q4 FY2026, 15 May 2026); ScanX and MarketsMojo (Q1 FY2027, 4 Aug 2026). Q3 FY2026 PAT derived as FY2026 PAT minus other three quarters; Q3/Q4 EPS derived.
Q1 FY2027 read-through. Sales were flat YoY (₹393.8 cr vs ₹393.4 cr) despite Kadiyam being shut for most of the quarter (production loss estimated by the company at ~205–220 MT/day and ~₹143 lakh/day of revenue during the disruption), which implies Rajahmundry ran hard and realisations firmed. Operating margin recovered to ~12.4% from ~8.5% a year earlier; PAT rose ~42% YoY to ₹30.3 cr.
Balance sheet
Sources: IIFL/Arihant (CMOTS) balance sheets FY2022–FY2025; StockAnalysis (cash, investments, PP&E, net cash; converted from ₹ million); NSE integrated filing and ScanX summary for FY2026 (cash ₹1,616.93 lakh, reserves ₹1,89,958.10 lakh, total assets ₹2,53,809.49 lakh, CWIP ₹27,895.71 lakh, financial liabilities incl. leases ₹23,215.29 lakh). Short-/long-term debt split for FY2026 is not publicly disclosed in sources reviewed; the secured/unsecured split is shown where available. Company "borrowings" per Annual Report 2024-25 were ₹277.8 cr (FY2025) and ₹108.6 cr (FY2024), slightly different from the CMOTS totals because of classification of current maturities/other items.
Commentary — balance sheet. Andhra Paper remains net-cash, but the cushion has shrunk from ₹763 cr (FY2024) to ₹289 cr (FY2026) as the company funded ~₹900 cr of cumulative capex over FY2024–FY2026 (PM upgrades, fibreline rebuild, recovery boiler, tissue machine) while profits fell. Gross debt rose from negligible levels to ₹283 cr in FY2025 (largely secured project/working-capital lines with SBI, HDFC, Axis, Yes Bank and ICICI per ICRA facility details), then eased to ₹232 cr in FY2026. Equity has been flat at ~₹1,940 cr for two years — earnings no longer outpace dividends materially. There is no goodwill; intangible assets are de minimis. Inventory build in FY2025 (₹322 cr) was a key drag on cash flow and partially unwound in FY2026.
Cash flow
Sources: Arthneeti cash-flow series (rounded to ₹ cr); capex derived. Dividends paid are approximations derived from per-share declarations paid in the following year (FY2024 dividend of ₹12.50/₹10 share and FY2025 payment flows not individually verified); treat as indicative. No buybacks have been announced in the period. Company-reported FY2026 net increase in cash was ₹12.35 cr and investing cash flow ₹1.74 cr (ScanX summary of the audited cash-flow statement).
Commentary — cash flow. Cumulative free cash flow over FY2024–FY2026 was approximately –₹526 cr (derived), funded by drawing down treasury investments and adding ₹180 cr of borrowings. FY2025's negative OCF reflects inventory and receivable build amid strikes and weak pricing. FY2026 capex (₹298 cr) included the tissue machine; with PM-3 (₹178 cr) still under way, FY2027 capex is likely to remain elevated, so a return to positive FCF depends on margin recovery.
Ratios
Notes: Current ratio not computed because current liabilities are not disclosed in the sources reviewed. ROIC uses a notional 25% tax rate; invested capital = equity + debt − cash & treasury investments. Negative net debt/EBITDA indicates net cash.
Ratio commentary. Returns have collapsed from cycle-peak levels (ROE 39% in FY2023) to ~1% in FY2026 — well below any reasonable cost of equity — while the cash conversion cycle worsened from ~16 days to ~70 days, reflecting inventory accumulation and a slower collection cycle as dealers destocked. Leverage remains very low, which is the main reason ICRA maintains an AA rating (assessed on a consolidated view with WCPM).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment revenue (INR Cr, standalone)
| Segment revenue (INR Cr, standalone) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Pulp, paper & paperboard — revenue from operations | 1,800.6 | 1,541.2 | 1,701.2 |
Pulp, paper & paperboard — profit before tax | 455.6 | 117.1 | 25.4 |
Segment ratios (%)
| Segment ratios (%) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Segment PBT margin (% of revenue from ops) | 25.3 | 7.6 | 1.5 |
Segment revenue YoY growth | -14.2 | -14.4 | 10.4 |
Contribution to total revenue | 100 | 100 | 100 |
Volume metric (MT)
| Volume metric (MT) | FY2025 | FY2026 |
|---|---|---|
Total paper sales | 226,288 | 260,438 |
Domestic paper sales | 217,269 | 258,550 |
Maplitho sales | 90,211 | 147,043 |
Non-maplitho sales (copier, cream wove, board, other) | 136,077 | 113,395 |
Income Statement and Financial Ratios (x)
| Metric (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations | 1,366.9 | 2,097.7 | 1,800.6 | 1,541.2 | 1,701.2 |
Turnover (net sales per company highlights) | 1,366.9 | 2,083.1 | 1,783.3 | 1,522.3 | 1,693.0 |
Total income (incl. other income) | — | — | 1,895.5 | 1,630.0 | 1,784.8 |
Gross profit (aggregator definition) | 529.1 | 1,031.5 | 694.3 | 484.1 | — |
EBITDA (company definition) | 265.8 | 786.7 | 525.9 | 223.3 | 150.9 |
Depreciation & amortisation | 72.0 | 63.2 | 65.9 | 88.3 | — |
Finance costs | 5.4 | 7.2 | 4.4 | 17.9 | — |
EBIT (PBT + finance costs, derived) | 193.4 | 708.2 | 460.0 | 135.0 | — |
Profit before tax | 188.0 | 701.0 | 455.6 | 117.1 | 25.4 |
Net income (PAT) | 140.0 | 522.4 | 339.7 | 88.9 | 18.6 |
EPS basic (INR, ₹2 FV) | 7.03 | 26.27 | 17.09 | 4.47 | 0.94 |
EPS diluted (INR, ₹2 FV) | 7.03 | 26.27 | 17.09 | 4.47 | 0.94 |
Dividend per share (INR, ₹2 FV equivalent) | 1.5 | 2.5 | — | 1.0 | 0.5 |
Margin / growth (%)
| Margin / growth (%) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross margin (aggregator) | 38.7 | 49.2 | 38.6 | 31.4 | — |
EBITDA margin (% of revenue from ops, derived) | 19.4 | 37.5 | 29.2 | 14.5 | 8.9 |
EBITDA margin (% of total income, company) | 19 | 37 | 28 | 14 | 8.5 |
EBIT margin (derived) | 14.1 | 33.8 | 25.5 | 8.8 | — |
PBT margin | 13.8 | 33.4 | 25.3 | 7.6 | 1.5 |
Net margin | 10.2 | 24.9 | 18.9 | 5.8 | 1.1 |
Revenue growth YoY | 54.2 | 53.5 | -14.2 | -14.4 | 10.4 |
Operating Metrics (MT) and Unit Economics (INR/tonne)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Paper production (MT) | 235,155 | 250,292 | 235,749 | 232,861 | 259,266 |
Paper sales (MT) | 240,479 | 250,238 | 233,480 | 226,288 | 260,438 |
Turnover per tonne sold (INR, derived) | 56,842 | 83,245 | 76,378 | 67,272 | 65,005 |
EBITDA per tonne sold (INR, derived) | 11,053 | 31,439 | 22,525 | 9,868 | 5,794 |
Income Statement and Per-Share Data
| Metric (INR Cr) | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|
Net sales | 393.4 | 362.1 | 418.7 | 527.1 | 393.8 |
Other income | 27.2 | 10.2 | — | — | 21.7 |
Total expenditure | 359.8 | 368.9 | 403.3 | 501.9 | — |
PBIDT | 60.8 | 3.4 | — | — | — |
Finance costs | 5.8 | 4.2 | — | 3.7 | — |
Depreciation | 25.9 | 26.9 | — | — | — |
Net profit | 21.3 | -20.3 | 9.9 | 7.7 | 30.3 |
EPS (INR) | 1.07 | -1.02 | 0.50 | 0.39 | 1.52 |
Balance Sheet
| Metric (INR Cr, 31 March) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets | — | — | — | 2,604.6 | 2,538.1 |
Cash & cash equivalents | 24.5 | 21.3 | 11.1 | 3.8 | 16.2 |
Cash + short-term investments + trading securities | 294.9 | 753.1 | 877.7 | 748.3 | 521.0 |
Long-term investments | 138.2 | 174.8 | 172.2 | 164.6 | 147.4 |
Inventories | 145.1 | 173.7 | 237.0 | 322.1 | 263.1 |
Trade receivables | 102.6 | 147.5 | 60.9 | 108.6 | 156.1 |
Property, plant & equipment (net) | 589.5 | 593.4 | 907.4 | 1,052.5 | 1,278.7 |
Capital work-in-progress | 7.7 | 29.4 | 113.7 | 29.8 | 279.0 |
Intangible assets | 3.2 | 13.0 | 1.6 | 1.1 | 0.2 |
Goodwill | 0 | 0 | 0 | 0 | 0 |
Total debt (borrowings) | 59.2 | 55.5 | 115.1 | 283.1 | 232.2 |
of which secured | 0 | 0 | 102.3 | 208.8 | — |
of which unsecured | 59.2 | 55.5 | 12.8 | 74.3 | — |
Net debt (negative = net cash) | -235.7 | -697.7 | -762.6 | -465.2 | -288.8 |
Shareholders' equity | 1,094.1 | 1,582.2 | 1,893.2 | 1,940.8 | 1,939.4 |
Net working capital (aggregator) | 204.1 | 169.3 | 127.5 | 337.5 | — |
Cash Flow and Per-Share Data
| Metric (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow | 202 | 536 | 319 | -55 | 104 |
Capital expenditure (derived = OCF − FCF) | 39 | 114 | 331 | 265 | 298 |
Free cash flow | 163 | 422 | -12 | -320 | -194 |
Investing cash flow (incl. treasury) | -181 | -498 | -334 | -61 | 2 |
Financing cash flow | -12 | -41 | 5 | 109 | -94 |
Dividends paid (derived from DPS × shares) | 15 | 30 | 50 | 20 | 10 |
Share buybacks | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE % (PAT / average equity, derived) | 13.5 | 39.0 | 19.5 | 4.6 | 1.0 |
ROA % (PAT / closing total assets, derived) | — | — | — | 3.4 | 0.7 |
ROIC % (EBIT × (1 − 25%) / (equity + debt − cash), derived) | 12.3 | 56.2 | 30.0 | 6.8 | — |
Debt / equity (x) | 0.05 | 0.04 | 0.06 | 0.15 | 0.12 |
Net debt / EBITDA (x) | -0.89 | -0.89 | -1.45 | -2.08 | -1.91 |
Interest coverage (EBITDA / finance costs, x) | 48.9 | 109.3 | 119.5 | 12.5 | — |
Asset turnover (revenue / total assets, x) | — | — | — | 0.59 | 0.67 |
Cash conversion cycle (days, aggregator) | 17 | 16 | 16 | 78 | 68 |
Geographic Revenue
| Geography (paper sales, MT) | FY2025 | FY2026 |
|---|---|---|
India (domestic) | 217,269 | 258,550 |
Exports | 9,019 | 1,888 |
Total | 226,288 | 260,438 |
Revenue by Region (%)
| Geography (% of sales volume) | FY2025 | FY2026 |
|---|---|---|
India | 96.0 | 99.3 |
Exports | 4.0 | 0.7 |
Valuation Snapshot
| Metric | Value |
|---|---|
Last close (16 Oct 2026) | ₹68.39 |
52-week high / low | ₹79.79 / ₹58.00 |
1-year return (16 Oct 2025 ₹78.10 → 16 Oct 2026, derived) | –12.4% |
3-year return (to Jan 2026, Business Standard) | –22.3% |
5-year return | Not computed (adjusted price history not available in sources reviewed) |
Average daily volume (1 month, NSE+BSE) | ~2.5 lakh shares |
Share price snapshots (INR, ₹2 FV basis) | Dec 2024 |
Closing price | 93.62 |
Market capitalisation (INR Cr) | 1,862 |
Valuation Multiples
| Multiple | Andhra Paper | Basis |
|---|---|---|
P/E (TTM to Q1 FY2027, PAT ₹27.6 cr) | 49.2x | Q2FY26 –20.3 + Q3FY26 9.9 + Q4FY26 7.7 + Q1FY27 30.3 |
P/E (FY2026) | 72.8x | PAT ₹18.6 cr |
EV/EBITDA (FY2026) | 7.1x | EV ≈ ₹1,071 cr (mkt cap 1,360 + debt 232 − cash & investments 521) |
EV/Sales (FY2026) | 0.63x | — |
P/B (Mar 2026 equity ₹1,939 cr) | 0.70x | — |
Dividend yield (FY2026 DPS ₹0.50) | 0.7% | — |
Dividend per share (INR, ₹2 FV equivalent)
| Dividend per share (INR, ₹2 FV equivalent) | FY2022 | FY2023 | FY2025 | FY2026 |
|---|---|---|---|---|
DPS | 1.5 | 2.5 | 1.0 | 0.5 |
Payout ratio % (derived) | 21.3 | 9.5 | 22.4 | 53.4 |
Credit Ratings
| Agency | Instrument | Rating | Outlook | Date |
|---|---|---|---|---|
ICRA | Long-term fund-based (₹306 cr) | [ICRA]AA | Stable | 28 Nov 2025 |
ICRA | LT/ST unallocated (₹19 cr) | [ICRA]AA / [ICRA]A1+ | Stable | 28 Nov 2025 |
ICRA | Short-term non-fund-based (₹25 cr) | [ICRA]A1+ | — | 28 Nov 2025 |
CARE Ratings | Bank facilities (same level) | Withdrawn | — | 2025 |
Moody's / S&P / Fitch | — | Not rated | — | — |
Analyst Conclusions
Management guidance
No numerical guidance is issued. Management's most recent operational message (4 Aug 2026) is that Kadiyam is back at ~93% of normal capacity and that full normalisation is being pursued. Capex commitments in hand are the tissue line (₹270 cr) and PM-3 rebuild (₹178 cr).
Consensus expectations
No formal consensus exists. Analyst framework (not a forecast of record): FY2027 revenue is likely to be constrained by the Q1 Kadiyam outage but supported by firmer domestic pricing and PM-3/tissue contributions only toward year-end; margins are more sensitive to realisation and wood costs than to volume.
Bull case
-
Trade protection inflects pricing. The DGTR countervailing-duty probe on Indonesian uncoated W&P (30 Sep 2026) targets precisely Andhra's maplitho/offset grades; even partial relief from import parity could restore several thousand rupees per tonne of EBITDA — each ₹1,000/MT on ~2.6 lakh MT is ~₹26 cr, larger than FY2026's entire PAT.
-
Capacity and mix tailwinds. Tissue (35,000 TPA) and PM-3 (+~20,000 TPA, derived) add ~20% to volume capacity by FY2028 on a fully funded basis, with tissue carrying structurally higher growth.
-
Asset backing. At 0.70x book, ~7x FY2026 EV/EBITDA and with ₹521 cr of cash and liquid investments (~38% of market cap), downside is cushioned; Q1 FY2027's 12.4% margin shows earnings can recover quickly.
Bear case
-
Structural import disadvantage. An estimated ~US$70/MT fibre-cost handicap versus ASEAN mills may cap realisations even with duties; copier paper is excluded from the new CVD scope.
-
Labour risk is chronic. Four disruptive episodes in ~27 months suggest unresolved contract-labour issues; each Kadiyam shutdown costs ~₹1.4 cr/day in revenue.
-
Value trap dynamics. ROE of ~1%, negative FCF for two years, rising capex and promoter control (72.45%) limit minority-shareholder upside; any WCPM-led restructuring would be on terms set by the controlling shareholder.
Catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable |
|---|---|
| Early Nov 2026 | Q2 FY2027 results — first full quarter of Kadiyam at ~93%+; compare against Q2 FY2026 loss of ₹20.3 cr |
| H2 FY2027 | Tissue machine commissioning announcement and ramp-up |
| ~Q3–Q4 FY2027 | PM-3 rebuild completion (13-month schedule from Aug 2025) |
| Rolling | DGTR CVD investigation on Indonesian uncoated W&P — preliminary findings; Finance Ministry action on paperboard ADD after MIP lapse (30 Sep 2026) |
| Rolling | Labour settlement at Kadiyam; any renewed strike notices |
| Rolling | Wood prices and realisation trends reported by peers (JK Paper, ITC, WCPM) |
| Nov 2026 | ICRA annual surveillance of AA(Stable) rating |
| May 2027 | FY2027 results, dividend decision, update on greenfield board project |
Analyst verdict
Andhra Paper is a fundamentally sound, integrated pulp-and-paper asset caught at the bottom of a cyclical and policy-driven downturn, and further impaired by self-inflicted operational disruption. The data tell a coherent story. Between FY2023 and FY2026, realisations fell roughly 22% while volumes rose to records, compressing EBITDA per tonne by over 80% and driving ROE from 39% to about 1%. Management responded by investing through the trough — almost ₹900 cr of capex over three years — financed by drawing down a once-ample treasury book and modest borrowing. The balance sheet remains net-cash and AA-rated, so solvency is not the issue; returns on capital are.
The investment debate therefore turns on three variables largely outside the company's control and one inside it. Outside: whether trade remedies against Indonesian supply materialise and stick; whether wood costs ease; and whether domestic notebook/textbook demand stays firm. Inside: whether management can secure durable labour peace at Kadiyam, where contract-worker grievances have now produced two shutdowns in two years. Q1 FY2027 — a 42% profit increase and 12.4% margins despite a month-long lockout — demonstrates real operating leverage when pricing cooperates.
At ~0.7x book and ~7x trailing EV/EBITDA, the market is pricing a prolonged trough. That is defensible given negative free cash flow and controlled-company governance, but it leaves meaningful upside if the CVD investigation leads to duties and the tissue and PM-3 projects are delivered in FY2027. Our stance is cautiously constructive, event-driven: the stock is a call option on Indian trade policy and execution, backed by tangible assets and parent support, rather than a compounding franchise. Investors should require evidence of (a) a full quarter without labour disruption, (b) tissue commissioning, and (c) sustained EBITDA above ~₹10,000/MT before underwriting a re-rating toward book value and beyond.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Since | Background / other roles |
|---|---|---|---|
Shree Kumar (S. K.) Bangur | Chairman (described as Non-Executive Chairman in 2025 board listing; earlier Chairman & Managing Director) | Oct 2019 | Chairman & MD of West Coast Paper Mills; chairman of several Bangur group companies (Jayashree Chemicals, The Diamond Company, Kilkotagiri & Thirumbadi Plantations, West Coast Opticable, among others) |
Virendraa Bangur | Vice Chairman | 2020 | Joint Managing Director of WCPM; director of Gloster Cables, Jayshree Chemicals |
Saurabh Bangur | Managing Director | 1 Jun 2020; re-appointed for 5 years w.e.f. 1 Oct 2026 (approved at 62nd AGM, 11 Aug 2026) | Bangur family member; credited in the re-appointment resolution with driving the company's modernisation capex and portfolio strengthening |
Mukesh Jain | Executive Director / Director (Commercial) | CFO from 1 Feb 2023; elevated to whole-time board role thereafter | Chartered accountant background (per MCA KMP record as CFO); public face of the Valmet tissue deal |
Sudarshan V. Somani | Independent Director | 2019 | Director of Somani-family investment companies |
Arun Kumar Sureka | Independent Director | 2019 | Not detailed in sources reviewed |
Virendra Sinha | Independent Director | — | Former CMD, Balmer Lawrie & Co.; director of Texmaco Rail & Engineering, Electrosteel Castings, TM International Logistics |
Papia Sengupta | Independent Director (woman director) | — | Not detailed in sources reviewed |
Deepak Jalan | Independent Director (first term, 3 years) | Aug 2025 | Promoter and MD of Linc Limited (writing instruments) |
Additional Independent Director (name not legible in sources reviewed) | Independent Director (first term, 3 years) | Aug 2025 | Former unit head of Alexandria Fibre Company (Egypt) and Grasim Bhiwani Textiles; chartered accountant and company secretary |
Bijay Kumar Sanku | Company Secretary & Compliance Officer | — | — |
Chief Financial Officer | — | — | The current CFO's identity after Mukesh Jain's elevation is not confirmed in sources reviewed |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
1 Feb 2023 | Mukesh Jain appointed CFO | Replaced Anish T. Mathew (exited Jan 2022) |
5 Aug 2025 | Two independent directors appointed (incl. Deepak Jalan) | Board compliance and refresh |
14 May 2026 | Board approved re-appointment of Saurabh Bangur as MD for 5 years | Effective 1 Oct 2026; shareholders approved 11 Aug 2026 |
Major Shareholders
| Holder | Shares | % | Type | Source / date |
|---|---|---|---|---|
West Coast Paper Mills Ltd | 144,063,000 | 72.45 | Promoter (public company) | Mar 2026 pattern (MarketsMojo); Simply Wall St |
ICICI Prudential Asset Management (incl. ICICI Pru Smallcap Fund 3.6%) | 8,550,054 | 4.30 | Mutual fund | Simply Wall St (Dec 2025) |
Lok Prakashan Ltd | 7,055,504 | 3.55 | Corporate (public shareholder) | Simply Wall St |
Raviraj Developers Ltd | 2,467,990 | 1.24 | Corporate | Simply Wall St |
Investor Education & Protection Fund | 518,905 | 0.26 | Government | Simply Wall St |
Dimensional Fund Advisors LP | 185,428 | 0.09 | Foreign institution | Simply Wall St |
American Century Investment Management | — | 0.07 | Foreign institution | Simply Wall St |
All mutual funds (2 schemes) | — | 5.41 | Category | MarketsMojo, Mar 2026 |
All FIIs (25) | — | 0.34 | Category | MarketsMojo, Mar 2026 |
Individual investors | — | 13.51 | Category | MarketsMojo, Mar 2026 |
Competitive Landscape
Key Competitors
| Competitor | Segment overlap | Scale indicator | Relative positioning vs Andhra Paper |
|---|---|---|---|
ITC Ltd – Paperboards & Specialty Papers Division (ITC-PSPD) | W&P, board, specialty | Paperboards, paper & packaging segment ~₹2,200 cr per quarter (Q2 FY2026) | Largest Indian player; far broader portfolio and fibre programme |
JK Paper Ltd | Office/copier, W&P, coated, packaging board | FY2026 sales ₹7,076 cr; PAT ₹265.8 cr (consolidated) | ~4x Andhra's revenue; strong copier brands; acquisitive in packaging |
West Coast Paper Mills Ltd (parent) | W&P, cupstock, specialty; 3.2 lakh MTPA paper | Group consolidated revenue ~₹4,076 cr (FY2025, ICRA) | Sister company; coordinated rather than competing |
Tamil Nadu Newsprint & Papers (TNPL) | W&P, board (bagasse-based) | Record production/sales FY2026; mkt cap ~₹2,050 cr (late 2025) | State-owned; bagasse fibre; direct southern competitor |
Seshasayee Paper & Boards | W&P, board | Q1 FY2026 total income ~₹399 cr; mkt cap ~₹2,250 cr (late 2025) | Similar scale, southern, export-exposed |
Aditya Birla Real Estate (Century Pulp & Paper) | W&P, tissue, board | Large integrated (Lalkuan) | North-based; also in tissue |
Bilt Graphic Paper Products (BGPPL) | Coated/uncoated woodfree | Large private | Co-applicant in 2026 CVD petition |
Orient Paper & Industries | W&P, tissue | Mid-size | Tissue overlap with Andhra's new line |
Kuantum Papers | W&P (agro/wood) | Small–mid | Northern competitor |
Satia Industries | W&P (agro-based) | Small–mid | Price-competitive maplitho |
Pudumjee Paper Products | Specialty, tissue | Small | Tissue overlap |
Imports: Asia Pulp & Paper (Indonesia), APRIL/RGE, Chinese mills | W&P, copier, board | Global scale | Primary price setters; subject of Indian trade remedies |
Peer Comparison FY2026
| Metric (FY2026 unless noted) | Andhra Paper | JK Paper (consolidated) | WCPM group (FY2025) | Seshasayee |
|---|---|---|---|---|
Revenue (INR Cr) | 1,701.2 | 7,076.0 | 4,076 | — |
Revenue growth YoY (%) | 10.4 | 6.2 | -8.5 | — |
EBITDA / operating margin (%) | 8.9 | 13.1 | 12.4 | — |
Net margin (%) | 1.1 | 3.8 | — | — |
Market cap (INR Cr, latest available) | 1,360 | ~6,600 (Nov 2025) | ~2,600 (Aug 2026) | ~2,250 (late 2025) |
“—” = not publicly disclosed.



